Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.52 |
| ▸ | TSHR | P16473 | 3/20 | 0.52 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.52 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.52 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.52 |
| ▸ | PGK1 | P00558 | 5/20 | 0.50 |
| ▸ | PGK2 | P07205 | 5/20 | 0.50 |
| ▸ | ENPP2 | Q13822 | 2/20 | 0.50 |
| ▸ | HDAC1 | Q13547 | 2/20 | 0.47 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.47 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.46 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.46 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.44 |
| ▸ | HTT | P42858 | 1/20 | 0.44 |
| ▸ | HPGD | P15428 | 2/20 | 0.43 |
| ▸ | MAPT | P10636 | 1/20 | 0.43 |
| ▸ | GAA | P10253 | 2/20 | 0.41 |
| ▸ | DGAT2 | Q96PD7 | 1/20 | 0.41 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.41 |
| ▸ | G6PD | P11413 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1617420 | 0.82 | PGK1 (0.67) | PGK1PGK2ENPP2DGAT2SMN1; SMN2 | |
| SCHEMBL16335457 | 0.81 | PGK1 (0.46) | ALDH1A1MAPK1PGK1PGK2ENPP2 | |
| SCHEMBL16353250 | 0.79 | PGK1 (0.50) | ALDH1A1TSHRPGK1PGK2ENPP2 | |
| SCHEMBL9512466 | 0.78 | ENPP2 (0.42) | PGK1PGK2ENPP2DGAT2 | |
| SCHEMBL16353269 | 0.76 | PGK1 (0.49) | ALDH1A1CYP3A4TDP1PGK1PGK2 | |
| SCHEMBL11304410 | 0.76 | ENPP2 (0.60) | ALDH1A1PGK1PGK2ENPP2DGAT2 | |
| SCHEMBL916486 | 0.76 | PGK1 (0.61) | TSHRPGK1PGK2ENPP2MAPT | |
| SCHEMBL9407120 | 0.75 | PGK1 (0.59) | PGK1PGK2ENPP2 | |
| SCHEMBL12960342 | 0.75 | HRH3 (0.63) | ALDH1A1TSHRPGK1PGK2ENPP2 | |
| SCHEMBL126802 | 0.74 | ENPP2 (0.46) | PGK1PGK2ENPP2HDAC6HTT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3013787-B1 | TRANSITION-METAL-FREE N-ARYLATION OF TERTIARY AMINES USING ARYNES | COUNCIL SCIENT IND RES (IN) | 2017-08-02 | — | — | EP | claimed |
| US-9650329-B2 | Transition-metal-free N-arylation of tertiary amines using arynes | COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) | 2017-05-16 | — | — | US | claimed |
| US-20160137587-A1 | TRANSITION-METAL-FREE N-ARYLATION OF TERTIARY AMINES USING ARYNES | COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) | 2016-05-19 | — | — | US | claimed |
| EP-3013787-A1 | TRANSITION-METAL-FREE N-ARYLATION OF TERTIARY AMINES USING ARYNES | Council of Scientific & Industrial Research (IN) | 2016-05-04 | — | — | EP | claimed |
| WO-2014207761-A1 | TRANSITION-METAL-FREE N-ARYLATION OF TERTIARY AMINES USING ARYNES | COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) | 2014-12-31 | — | — | WO | claimed |
| EP-3013787-B1 | TRANSITION-METAL-FREE N-ARYLATION OF TERTIARY AMINES USING ARYNES | COUNCIL SCIENT IND RES (IN) | 2017-08-02 | — | — | EP | disclosed |
| US-9650329-B2 | Transition-metal-free N-arylation of tertiary amines using arynes | COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) | 2017-05-16 | — | — | US | disclosed |
| US-20160137587-A1 | TRANSITION-METAL-FREE N-ARYLATION OF TERTIARY AMINES USING ARYNES | COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) | 2016-05-19 | — | — | US | disclosed |
| EP-3013787-A1 | TRANSITION-METAL-FREE N-ARYLATION OF TERTIARY AMINES USING ARYNES | Council of Scientific & Industrial Research (IN) | 2016-05-04 | — | — | EP | disclosed |
| WO-2014207761-A1 | TRANSITION-METAL-FREE N-ARYLATION OF TERTIARY AMINES USING ARYNES | COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) | 2014-12-31 | — | — | WO | disclosed |
| WO-2011141515-A1 | DIAGNOSTIC AGENTS FOR AMYLOID BETA IMAGING | BAYER PHARMA AKTIENGESELLSCHAFT (DE) | 2011-11-17 | — | — | WO | disclosed |
| US-6090969-A | REACTING AN OPTICALLY ACTIVE BINAPHTHOL WITH AN ALKALI METAL ALUMINUM HYDRIDE OR A DIALKYLALUMINUM HYDRIDE AND AN ALKALI OR ALKALINE EARTH METAL BASE | NAGASE AND CO., LTD. (JP) | 2000-07-18 | — | — | US | disclosed |
| US-5847186-A | Process for preparing asymmetric compound by using metal complex | NAGASE & COMPANY, LTD. (JP) | 1998-12-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160137587-A1 | TRANSITION-METAL-FREE N-ARYLATION OF TERTIARY AMINES USING ARYNES | CDK6, NEK6, MCM6 | ALDH1A1 1357/4885TSHR 1941/4885MAPK1 2557/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.